Back to Top
Alirocumab Biosimilar - Research Grade
Add recommended extras
Alirocumab Biosimilar - Research Grade
| Concentration | 1.0 - 5.0 mg/ml |
|---|---|
| Isotype | Human IgG1 |
| Host | Humanized |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human PCSK9. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Alirocumab. |
| Species Reactivity | Human |
| Target | PCSK9 |
| Shipping Conditions | Blue ice |
| background | Alirocumab biosimilar is a human monoclonal antibody (IgG1 isotype) that targets proprotein convertase subtilisin kexin type 9 (PCSK9), is a PCSK9 inhibitor produced by recombinant DNA technology in Chinese Hamster Ovary cell suspension culture. Alirocuma |
| Other names | Proprotein convertase subtilisin/kexin type 9, NARC-1, PC9 |
| UniProt | Q8NBP7 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |
Write Your Own Review
Who Viewed This Also Viewed
Bulk Anti-Human CD195 (HEK/1/85a/7a) Antibody (CCR5)
$390.00 - $3,702.00
Mouse Anti-Mouse PD-L1 (10F.9G2) Recombinant Antibody
$612.00 - $4,590.00
